0001035267-24-000122.txt : 20240311 0001035267-24-000122.hdr.sgml : 20240311 20240311201127 ACCESSION NUMBER: 0001035267-24-000122 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240308 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeSantis Robert CENTRAL INDEX KEY: 0001808942 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30713 FILM NUMBER: 24739867 MAIL ADDRESS: STREET 1: C/O INTUITIVE SURGICAL, INC. STREET 2: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC CENTRAL INDEX KEY: 0001035267 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770416458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4085232100 MAIL ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-03-08 0 0001035267 INTUITIVE SURGICAL INC ISRG 0001808942 DeSantis Robert 1020 KIFER ROAD SUNNYVALE CA 94086 0 1 0 0 EVP & Chief Strategy & Corp Op 1 Common Stock 2024-03-08 4 M 0 1504 290.33 A 12579 D Common Stock 2024-03-08 4 S 0 1504 393.808 D 11075 D Common Stock 2024-03-08 4 M 0 7149 347.4167 A 18224 D Common Stock 2024-03-08 4 S 0 7149 393.775 D 11075 D Common Stock 2024-03-08 4 M 0 993 245.6 A 12068 D Common Stock 2024-03-08 4 S 0 993 393.8026 D 11075 D Common Stock 2024-03-08 4 M 0 453 242.3367 A 11528 D Common Stock 2024-03-08 4 S 0 453 393.8026 D 11075 D Common Stock 2024-03-08 4 M 0 363 179.7 A 11438 D Common Stock 2024-03-08 4 S 0 363 393.7969 D 11075 D Common Stock 2024-03-08 4 M 0 453 177.9867 A 11528 D Common Stock 2024-03-08 4 S 0 453 393.7969 D 11075 D Common Stock 2024-03-08 4 M 0 1437 304.67 A 12512 D Common Stock 2024-03-08 4 S 0 1437 393.802 D 11075 D Common Stock 2024-03-08 4 M 0 1436 229.39 A 12511 D Common Stock 2024-03-08 4 S 0 1436 393.8164 D 11075 D Common Stock 2024-03-08 4 M 0 940 208.9 A 12015 D Common Stock 2024-03-08 4 S 0 940 393.8164 D 11075 D Common Stock 2024-03-08 4 S 0 2819 393.7942 D 8256 D Common Stock 2024-03-08 4 S 0 2749 393.8309 D 5507 D Common Stock 2024-03-11 4 M 0 90 179.7 A 5597 D Common Stock 2024-03-11 4 S 0 90 390.16 D 5507 D Common Stock 2024-03-11 4 M 0 119 304.67 A 5626 D Common Stock 2024-03-11 4 S 0 119 390.16 D 5507 D Common Stock 2024-03-11 4 M 0 120 229.39 A 5627 D Common Stock 2024-03-11 4 S 0 120 390.16 D 5507 D Non-Qualified Stock Option (right to buy) 177.9867 2024-03-08 4 M 0 453 0.0 D 2030-02-28 Common Stock 453 0 D Non-Qualified Stock Option (right to buy) 179.7 2024-03-08 4 M 0 363 0.0 D 2030-05-11 Common Stock 363 270 D Non-Qualified Stock Option (right to buy) 179.7 2024-03-11 4 M 0 90 0.0 D 2030-05-11 Common Stock 90 180 D Non-Qualified Stock Option (right to buy) 208.9 2024-03-08 4 M 0 940 0.0 D 2029-08-28 Common Stock 940 4511 D Non-Qualified Stock Option (right to buy) 229.39 2024-03-08 4 M 0 1436 0.0 D 2030-02-27 Common Stock 1436 4310 D Non-Qualified Stock Option (right to buy) 229.39 2024-03-11 4 M 0 120 0.0 D 2030-02-27 Common Stock 120 4190 D Non-Qualified Stock Option (right to buy) 242.3367 2024-03-08 4 M 0 453 0.0 D 2030-08-28 Common Stock 453 0 D Non-Qualified Stock Option (right to buy) 245.6 2024-03-08 4 M 0 993 0.0 D 2031-02-26 Common Stock 993 2382 D Non-Qualified Stock Option (right to buy) 290.33 2024-03-08 4 M 0 1504 0.0 D 2029-02-28 Common Stock 1504 4512 D Non-Qualified Stock Option (right to buy) 304.67 2024-03-08 4 M 0 1437 0.0 D 2030-08-09 Common Stock 1437 4309 D Non-Qualified Stock Option (right to buy) 304.67 2024-03-11 4 M 0 119 0.0 D 2030-08-09 Common Stock 119 4190 D Non-Qualified Stock Option (right to buy) 347.4167 2024-03-08 4 M 0 7149 0.0 D 2031-08-26 Common Stock 7149 2382 D These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 327 shares sold at $391.89 to $392.02; 1,077 shares sold at $393.73 to $394.61; and 100 shares sold at $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.05 as follows: 1,277 shares sold at $391.89 to $392.02; 157 shares sold at $392.50 to $392.52; 4,145 shares sold at $393.53 to $394.53; and 1,570 shares sold at $394.56 to $395.05. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 318 shares sold at $391.89 to $392.02; 1,028 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.80 as follows: 223 shares sold at $391.89 to $392.02 and 593 shares sold at $394.00 to $394.80. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 317 shares sold at $391.89 to $392.02; 1,020 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.32 as follows: 458 shares sold at $391.89 to $392.02; 780 shares sold at $393.22 to $394.14; 1,134 shares sold at $394.27 to $394.82; and 4 shares sold at $395.32. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 525 shares sold at $391.89 to $392.02; 1,876 shares sold at $393.55 to $394.53; and 418 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 515 shares sold at $391.89 to $392.02; 2,034 shares sold at $393.65 to $394.61; and 200 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. By: Donna Spinola For: DeSantis, Robert 2024-03-11